INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 99 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 729 | -98.3% | 0.00% | – |
| Q1 2022 | $48,000 | -48.9% | 41,729 | 0.0% | 0.00% | – |
| Q4 2021 | $94,000 | -34.3% | 41,729 | -0.5% | 0.00% | – |
| Q3 2021 | $143,000 | -36.2% | 41,936 | -44.1% | 0.00% | – |
| Q2 2021 | $224,000 | +54.5% | 75,000 | +67.4% | 0.00% | – |
| Q1 2017 | $145,000 | +141.7% | 44,801 | +0.0% | 0.00% | – |
| Q4 2016 | $60,000 | -14.3% | 44,800 | 0.0% | 0.00% | – |
| Q3 2016 | $70,000 | +16.7% | 44,800 | 0.0% | 0.00% | – |
| Q2 2016 | $60,000 | -74.6% | 44,800 | 0.0% | 0.00% | – |
| Q1 2016 | $236,000 | -33.0% | 44,800 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $352,000 | -7.1% | 44,800 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $379,000 | -34.8% | 44,800 | -15.6% | 0.00% | 0.0% |
| Q2 2015 | $581,000 | +98.3% | 53,082 | +153.4% | 0.00% | – |
| Q1 2015 | $293,000 | – | 20,950 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 17,426,968 | $36,945,000 | 1.45% |
| Opaleye Management Inc. | 3,171,800 | $6,724,000 | 0.88% |
| EAM Investors, LLC | 421,103 | $893,000 | 0.15% |
| Bleichroeder LP | 250,000 | $530,000 | 0.10% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 755,593 | $1,602,000 | 0.04% |
| Callan Capital, LLC | 73,200 | $155,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 419,300 | $889,000 | 0.02% |
| Private Wealth Advisors, Inc. | 12,000 | $25,000 | 0.01% |
| Alpine Global Management, LLC | 24,575 | $52,000 | 0.01% |
| Evercore Wealth Management, LLC | 143,138 | $303,000 | 0.01% |